Literature DB >> 27893956

Human Vaccines & Immunotherapeutics: News.

.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27893956      PMCID： PMC7001740          DOI： 10.1080/21645515.2016.1253965

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN： 2164-5515            Impact factor:   3.452


× No keyword cloud information.
  6 in total

1.  Immunotherapy of non-Hodgkin's lymphoma with a defined ratio of CD8+ and CD4+ CD19-specific chimeric antigen receptor-modified T cells.

Authors:  Cameron J Turtle; Laïla-Aïcha Hanafi; Carolina Berger; Michael Hudecek; Barbara Pender; Emily Robinson; Reed Hawkins; Colette Chaney; Sindhu Cherian; Xueyan Chen; Lorinda Soma; Brent Wood; Daniel Li; Shelly Heimfeld; Stanley R Riddell; David G Maloney
Journal:  Sci Transl Med       Date:  2016-09-07       Impact factor: 17.956

2.  Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older.

Authors:  Anthony L Cunningham; Himal Lal; Martina Kovac; Roman Chlibek; Shinn-Jang Hwang; Javier Díez-Domingo; Olivier Godeaux; Myron J Levin; Janet E McElhaney; Joan Puig-Barberà; Carline Vanden Abeele; Timo Vesikari; Daisuke Watanabe; Toufik Zahaf; Anitta Ahonen; Eugene Athan; Jose F Barba-Gomez; Laura Campora; Ferdinandus de Looze; H Jackson Downey; Wayne Ghesquiere; Iris Gorfinkel; Tiina Korhonen; Edward Leung; Shelly A McNeil; Lidia Oostvogels; Lars Rombo; Jan Smetana; Lily Weckx; Wilfred Yeo; Thomas C Heineman
Journal:  N Engl J Med       Date:  2016-09-15       Impact factor: 91.245

3.  Substantial Decline in Vaccine-Type Human Papillomavirus (HPV) Among Vaccinated Young Women During the First 8 Years After HPV Vaccine Introduction in a Community.

Authors:  Jessica A Kahn; Lea E Widdice; Lili Ding; Bin Huang; Darron R Brown; Eduardo L Franco; David I Bernstein
Journal:  Clin Infect Dis       Date:  2016-09-20       Impact factor: 9.079

4.  Benefits and risks of the Sanofi-Pasteur dengue vaccine: Modeling optimal deployment.

Authors:  Neil M Ferguson; Isabel Rodríguez-Barraquer; Ilaria Dorigatti; Luis Mier-Y-Teran-Romero; Daniel J Laydon; Derek A T Cummings
Journal:  Science       Date:  2016-09-02       Impact factor: 47.728

5.  Randomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancer.

Authors:  Angus G Dalgleish; Justin Stebbing; Douglas Ja Adamson; Seema Safia Arif; Paolo Bidoli; David Chang; Sue Cheeseman; Robert Diaz-Beveridge; Carlos Fernandez-Martos; Rob Glynne-Jones; Cristina Granetto; Bartomeu Massuti; Karen McAdam; Raymond McDermott; Andrés J Muñoz Martín; Demetris Papamichael; Roberto Pazo-Cid; Jose M Vieitez; Alberto Zaniboni; Kevin J Carroll; Shama Wagle; Andrew Gaya; Satvinder S Mudan
Journal:  Br J Cancer       Date:  2016-09-06       Impact factor: 7.640

6.  A polyvalent inactivated rhinovirus vaccine is broadly immunogenic in rhesus macaques.

Authors:  Sujin Lee; Minh Trang Nguyen; Michael G Currier; Joe B Jenkins; Elizabeth A Strobert; Adriana E Kajon; Ranjna Madan-Lala; Yury A Bochkov; James E Gern; Krishnendu Roy; Xiaoyan Lu; Dean D Erdman; Paul Spearman; Martin L Moore
Journal:  Nat Commun       Date:  2016-09-22       Impact factor: 14.919
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.